These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3274862)

  • 1. Serologic response to donor-specific blood transfusions under azathioprine immunosuppression.
    Etheredge EE; Bettonville P; Sicard GA; Tyler J; Anderson CB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):746-7. PubMed ID: 3274862
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 response inhibition following donor specific transfusions given with azathioprine.
    Tyler JD; Anderson CB; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2258-61. PubMed ID: 3547923
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor specific transfusions: a five-year experience with alternative protocols.
    Norman DJ; Henell K; Fletcher L; Barry J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2252-4. PubMed ID: 3274504
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary experience with cadaveric donor-specific platelet transfusions (CDSPT) prior to kidney transplantation.
    Land W; Heim M; Scholz S; Mempel W; Illner WD; Castro LA; Schödel F
    Neth J Med; 1985; 28(6):262-4. PubMed ID: 3892328
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor-specific and random transfusions in HLA-haploidentical kidney transplantation.
    Garcia LF; Arango AM; Rezonzew R; Correa M; Angel B; Guzman B; Paris SC; Arbelaez M; Henao JE; Mejia G
    Transplant Proc; 1991 Apr; 23(2):1744-6. PubMed ID: 2053141
    [No Abstract]   [Full Text] [Related]  

  • 8. Early acute tubular necrosis, late rejection in pediatric renal transplantation with donor-specific transfusions.
    Chavers BM; Nevins TE; Knaack M; Melvin T; Mauer SM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1526-7. PubMed ID: 3274372
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor specific blood transfusion in renal transplantation: analysis of 22 cases.
    Casadei DH; Cambariere R; Leanza H; Najún Zarazaga C; Vilá N; Cristaldo L
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2274-5. PubMed ID: 3079079
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of antidonor mixed lymphocyte culture responses in donor specific transfusions plus azathioprine-treated patients.
    Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2255-7. PubMed ID: 2978892
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal transplantation in children.
    Gradus D; Ettenger RB
    Pediatr Clin North Am; 1982 Aug; 29(4):1013-38. PubMed ID: 7050858
    [No Abstract]   [Full Text] [Related]  

  • 13. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 15. Single center experience of 1000 primary living donor kidney transplants: univariate and multivariate analysis of risk factors affecting graft survival.
    Park K; Kim YS; Oh CK; Lee HY; Han DS; Lee JS; Kim PK
    Transplant Proc; 1994 Aug; 26(4):2159-60. PubMed ID: 8066708
    [No Abstract]   [Full Text] [Related]  

  • 16. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific transfusions in living-related transplantation.
    Salvatierra O
    World J Surg; 1986 Jun; 10(3):361-8. PubMed ID: 3524024
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies.
    Duffy B; Tyler J; Anderson C; Hanto D; Flye W; Rodey G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):753-4. PubMed ID: 2978930
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor-specific transfusions in renal transplantation in children. Effect of azathioprine plus transfusions.
    Friedman A; Deierhoi M; Chesney R; Sollinger H; Belzer F
    Transplantation; 1987 Jul; 44(1):159-61. PubMed ID: 3299916
    [No Abstract]   [Full Text] [Related]  

  • 20. Transplant outcome of desensitized recipients after donor-specific transfusion.
    Okazaki H; Takahashi H; Oguma S; Jimbo M; Ishizaki M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):750-2. PubMed ID: 3274863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.